banner ad

Tag: Orthofix

Orthofix International Comments on Competitor’s Statements on Investor Call

Akillas | April 26, 2010 | 0 Comments
Orthofix International Comments on Competitor’s Statements on Investor Call

Press Release Source: Orthofix International N.V. On Wednesday April 21, 2010 BOSTON–(BUSINESS WIRE)–Orthofix International N.V. (NASDAQ:OFIX – News) (the Company) today responded to public comments made yesterday by NuVasive, Inc. during their first quarter earnings call stating that a dispute has been initiated against the Company. The comments indicated that the dispute apparently concerns the [...]

Continue Reading

NuVasive Initiates “Legal Dispute” Over Stem Cell IP

Akillas | April 26, 2010 | 0 Comments
NuVasive Initiates “Legal Dispute” Over Stem Cell IP

BY LAUREN UZDIENSKI, APRIL 21, 2010 Yesterday afternoon on their 1Q:10 conference call, NuVasive revealed that they initiated a “legal dispute” against Orthofix over IP related to Osteocel, the stem-cell-based bone graft substitute acquired by NuVasive from Osiris in 2008. The details of this dispute were not revealed, but NuVasive vowed to “aggressively defend” their [...]

Continue Reading

Orthofix International Appoints Kevin L. Unger as President of Spinal Implants Division

Akillas | August 18, 2009 | 0 Comments
Orthofix International Appoints Kevin L. Unger as President of Spinal Implants Division

BOSTON–(HSMN NewsFeed)–Orthofix International N.V. (NASDAQ: OFIX ) announced today that Kevin L. Unger has been appointed as President of the Company’s spinal implants division. Mr. Unger will report directly to Brad Mason, who was previously named Group President of North America and has been serving as the President of Orthofix Spinal Implants since September of last [...]

Continue Reading

Orthofix International Receives CE Marking for Advent Cervical Disc

Akillas | July 16, 2009 | 0 Comments
Orthofix International Receives CE Marking for Advent Cervical Disc

BOSTON–(HSMN NewsFeed)–Orthofix International N.V. (NASDAQ: OFIX ) (the Company) announced today that the Company has received CE Marking for its Advent(TM) Cervical Disc, allowing it to begin selling the new device in Europe. “Receiving our CE Marking for Advent is an important step in our plans for the global commercialization of our first artificial cervical [...]

Continue Reading